Literature DB >> 28286113

CD4+ FoxP3+ T regulatory cell subsets in myasthenia gravis patients.

Siegfried Kohler1, Thomas Oskar Philipp Keil2, Sarah Hoffmann2, Marc Swierzy3, Mahmoud Ismail3, Jens Carsten Rückert3, Tobias Alexander4, Andreas Meisel5.   

Abstract

Although myasthenia gravis (MG) is a classic autoantibody-mediated disease, T cells are centrally involved in its pathogenesis. In recent years a number of studies have analyzed the role of CD4+ FoxP3+ regulatory T cells (Treg) in the disease with contradictory results. Here, the generation of Treg was significantly reduced in thymoma as compared to thymic hyperplasia and normal thymus tissue (p=0.0002). In the peripheral blood, Treg subsets classified according to CD49d, HELIOS and CD45RA expression changed after thymectomy and in the long-term course of immunosuppression. Compared to healthy volunteers the frequency of CD45RA+FoxP3low Treg was reduced in MG patients in general (p=0.037) and in particular in patients without immunosuppression (p=0.036). In our study, thymectomy and immunosuppressive treatment were associated with changes in Treg subpopulations. The reduced frequency of CD45RA+FoxP3low Treg we observed in MG patients might play a role in MG pathogenesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Myasthenia gravis; Regulatory T cells; Thymus

Mesh:

Substances:

Year:  2017        PMID: 28286113     DOI: 10.1016/j.clim.2017.03.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy.

Authors:  Scott Brian Minchenberg; Geeta Chaparala; Zachary Oaks; Katalin Banki; Andras Perl
Journal:  Clin Immunol       Date:  2018-07-17       Impact factor: 3.969

2.  Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis.

Authors:  Jie Rao; Siyu Li; Qiyu Wang; Qi Cheng; Yu Ji; Wenwen Fu; Hui Huang; Ling Shi; Xiaorong Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-09

3.  The LINC00452/miR-204/CHST4 Axis Regulating Thymic Tregs Might Be Involved in the Progression of Thymoma-Associated Myasthenia Gravis.

Authors:  Fuqiang Wang; Hanlu Zhang; Guanghao Qiu; Zhiyang Li; Yun Wang
Journal:  Front Neurol       Date:  2022-03-30       Impact factor: 4.003

Review 4.  Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.

Authors:  A Uzawa; S Kuwabara; S Suzuki; T Imai; H Murai; Y Ozawa; M Yasuda; Y Nagane; K Utsugisawa
Journal:  Clin Exp Immunol       Date:  2020-12-03       Impact factor: 5.732

5.  A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1-T146.

Authors:  Alessandra Consonni; Sapna Sharma; Karin Schön; Cristina Lebrero-Fernández; Elena Rinaldi; Nils Yngve Lycke; Fulvio Baggi
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

6.  Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.

Authors:  Frédérique Truffault; Dani Nazzal; Julien Verdier; Angeline Gradolatto; Elie Fadel; Régine Roussin; Bruno Eymard; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

Review 7.  Immunoregulatory Cells in Myasthenia Gravis.

Authors:  Ying Wu; Jie Luo; Oliver A Garden
Journal:  Front Neurol       Date:  2020-12-15       Impact factor: 4.003

8.  FoxP3- Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines.

Authors:  Huanyu Meng; Shuyu Zheng; Qinming Zhou; Yining Gao; You Ni; Huafeng Liang; Sheng Chen
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

9.  Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy.

Authors:  Wenhua Xu; Mingshan Ren; Swagata Ghosh; Kai Qian; Zhaofeng Luo; Aimei Zhang; Cuiping Zhang; Jiajun Cui
Journal:  Mediators Inflamm       Date:  2020-02-14       Impact factor: 4.711

Review 10.  Neuromuscular complications following targeted therapy in cancer patients: beyond the immune checkpoint inhibitors. Case reports and review of the literature.

Authors:  Chiara Demichelis; Andrea Balestra; Caterina Lapucci; Angela Zuppa; Stefano G Grisanti; Valeria Prada; Giampaola Pesce; Ilaria Grasso; Paola Queirolo; Angelo Schenone; Luana Benedetti; Marina Grandis
Journal:  Neurol Sci       Date:  2020-08-11       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.